Insight Molecular Diagnostics Inc. Common Stock

IMDXNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
5.24 USD
↘ 1.31 (20.00%)AT CLOSE (11:59 AM EDT)
5.30
↗ 0.06 (1.22%)
POST MARKET (AS OF 07:14 PM EDT)
Post Market
AS OF 07:14 PM EDT
5.30
↗ 0.06 (1.22%)
🔴Market: CLOSED
Open?$6.55
High?$6.55
Low?$5.20
Prev. Close?$6.55
Volume?292.2K
Avg. Volume?417.2K
VWAP?$5.76
Rel. Volume?0.70x
Bid / Ask
Bid?$4.37 × 100
Ask?$8.16 × 100
Spread?$3.79
Midpoint?$6.27
Valuation & Ratios
Market Cap?211.5M
Shares Out?32.3M
Float?25.5M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-19.78
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A

Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $5.26. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (447.5%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & Diagnostics
Employees
58
Market Cap
211.5M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.imdxinc.com
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.43Distress
Confidence?29%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.64%Low
Short Interest?1.2M
Days to Cover?2.1
Free Float25.5M
Avg Daily Volume561.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.48Strong
Quick Ratio?2.45Strong
Cash Ratio?2.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-19.78CHEAP▾
P/S?
Peers
100
S&P
3
108.52HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
94.05HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
447.5%STRONG▾
ROA?
S&P
3
-118.3%WEAK▾
Cash Flow & Enterprise
FCF?$-27456000
Enterprise Value?$183.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist